HK1137415A1 - Positively charged water-soluble prodrugs of mustards and related compounds with very high skin penetration rates - Google Patents

Positively charged water-soluble prodrugs of mustards and related compounds with very high skin penetration rates

Info

Publication number
HK1137415A1
HK1137415A1 HK10100931.0A HK10100931A HK1137415A1 HK 1137415 A1 HK1137415 A1 HK 1137415A1 HK 10100931 A HK10100931 A HK 10100931A HK 1137415 A1 HK1137415 A1 HK 1137415A1
Authority
HK
Hong Kong
Prior art keywords
mustards
positively charged
related compounds
skin penetration
charged water
Prior art date
Application number
HK10100931.0A
Other languages
English (en)
Chinese (zh)
Inventor
于崇曦
徐麗娜
Original Assignee
于崇曦
上海泰飛爾生化技術有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 于崇曦, 上海泰飛爾生化技術有限公司 filed Critical 于崇曦
Publication of HK1137415A1 publication Critical patent/HK1137415A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2404Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/242Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of hydroxyaryl compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2404Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2429Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of arylalkanols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2454Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2458Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK10100931.0A 2006-10-03 2010-01-28 Positively charged water-soluble prodrugs of mustards and related compounds with very high skin penetration rates HK1137415A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2006/053619 WO2008041059A1 (en) 2006-10-03 2006-10-03 Positively charged water-soluble prodrugs of mustards and related compounds with very high skin penetration rates

Publications (1)

Publication Number Publication Date
HK1137415A1 true HK1137415A1 (en) 2010-07-30

Family

ID=39268129

Family Applications (3)

Application Number Title Priority Date Filing Date
HK10100931.0A HK1137415A1 (en) 2006-10-03 2010-01-28 Positively charged water-soluble prodrugs of mustards and related compounds with very high skin penetration rates
HK15103662.4A HK1203188A1 (en) 2006-10-03 2015-04-15 Positively charged water-soluble prodrugs of mustards and related compounds with very high skin penetration rates
HK16104109.2A HK1216096A1 (zh) 2006-10-03 2016-04-11 具有快速皮膚穿透速度的帶正電荷的水溶性的芥子類化合物及其相關化合物的前藥

Family Applications After (2)

Application Number Title Priority Date Filing Date
HK15103662.4A HK1203188A1 (en) 2006-10-03 2015-04-15 Positively charged water-soluble prodrugs of mustards and related compounds with very high skin penetration rates
HK16104109.2A HK1216096A1 (zh) 2006-10-03 2016-04-11 具有快速皮膚穿透速度的帶正電荷的水溶性的芥子類化合物及其相關化合物的前藥

Country Status (5)

Country Link
US (3) US10189774B2 (xx)
EP (2) EP2792670A1 (xx)
CN (1) CN101511774B (xx)
HK (3) HK1137415A1 (xx)
WO (1) WO2008041059A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
KR101853971B1 (ko) 2007-06-04 2018-05-02 테크필즈 인크 매우 높은 피부 및 막 침투율을 가지는 비스테로이드성 소염제(nsaia) 약물전구체 및 이들의 새로운 의약적 용도
BRPI0922263B1 (pt) * 2008-12-04 2021-08-31 Chongxi Yu Composição de alta penetração de um fármaco principal, e seus usos
IN2014KN02583A (xx) 2012-01-18 2015-05-08 Techfields Pharma Co Ltd
MX2015012559A (es) 2013-03-15 2016-07-18 Techfields Pharma Co Ltd Novedosos fármacos de alta penetración y sus composiciones para el tratamiento de enfermedades de parkinson.
CN108627380B (zh) * 2017-03-15 2020-10-20 中国人民解放军军事医学科学院毒物药物研究所 去除或减少有毒物质的方法以及检测有毒物质的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091552A (en) 1986-06-30 1992-02-25 Board Of Regents, The University Of Texas System Novel antitumor aldophosphamide analogs
US5773435A (en) 1987-08-04 1998-06-30 Bristol-Myers Squibb Company Prodrugs for β-lactamase and uses thereof
EP0569046B1 (en) 1988-09-06 2002-11-13 Pharmacia Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5691371A (en) 1993-05-25 1997-11-25 Auckland Uniservices Limited Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents
KR100270650B1 (ko) * 1994-12-23 2000-11-01 돈 리사 로얄 돌연변이된 숙주효소를 이용한 항체-지시된 효소 전구약제 치료
GB9501052D0 (en) 1995-01-19 1995-03-08 Cancer Res Campaign Tech Improvements relating to prodrugs
US5659061A (en) 1995-04-20 1997-08-19 Drug Innovation & Design, Inc. Tumor protease activated prodrugs of phosphoramide mustard analogs with toxification and detoxification functionalities
DE19636889A1 (de) * 1996-09-11 1998-03-12 Felix Dr Kratz Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel
US6137003A (en) * 1998-10-28 2000-10-24 Shionogi Bioresearch Bis (haloethyl) aminobenzene derivatives
GB9907414D0 (en) 1999-03-31 1999-05-26 Cancer Res Campaign Tech Improvements relating to prodrugs
FR2795412B1 (fr) 1999-06-23 2001-07-13 Adir Nouveaux derives d'ammonium quaternaire, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU3104301A (en) * 2000-01-20 2001-07-31 Noven Pharmaceuticals, Inc. Compositions and methods to effect the release profile in the transdermal administration of active agents
GB0102239D0 (en) 2001-01-29 2001-03-14 Cancer Res Ventures Ltd Methods of chemical synthisis

Also Published As

Publication number Publication date
WO2008041059A1 (en) 2008-04-10
US20230097823A1 (en) 2023-03-30
US20100069336A1 (en) 2010-03-18
EP2077991A4 (en) 2011-11-16
CN101511774B (zh) 2015-05-13
US11479527B2 (en) 2022-10-25
EP2077991B1 (en) 2014-02-26
US20190233367A1 (en) 2019-08-01
HK1203188A1 (en) 2015-10-23
HK1216096A1 (zh) 2016-10-14
CN101511774A (zh) 2009-08-19
US10189774B2 (en) 2019-01-29
EP2792670A1 (en) 2014-10-22
EP2077991A1 (en) 2009-07-15

Similar Documents

Publication Publication Date Title
HK1215805A1 (zh) 具有快速皮膚穿透速度的帶正電荷的水溶性雙氯芬酸前藥
HK1202524A1 (en) Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates
EP2061749A4 (en) POSITIVELY CHARGED WATER-SOLUBLE PRODRUGS OF ACETAMINOPHEN AND COMPOUNDS ASSOCIATED WITH VERY HIGH SKIN PENETRATION SPEED
HK1135958A1 (en) Positively charged water-soluble prodrugs of ibuprofen with very fast skin penetration rate
HK1136814A1 (en) Positively charged water-soluble prodrugs of diflunisal and related compounds with very fast skin penetration rate
HK1216096A1 (zh) 具有快速皮膚穿透速度的帶正電荷的水溶性的芥子類化合物及其相關化合物的前藥
EP2084165A4 (en) PRO-DRUGS OF WATER-SOLUBLE OXICAMS POSITIVE AND RELATED COMPOUNDS WITH VERY HIGH SKIN PENETRATION SPEED
HK1243713A1 (zh) 一種化合物的固體形式及其使用方法
PL2125697T3 (pl) Dodatnio naładowane, rozpuszczalne w wodzie proleki retinoidów i związków podobnych do retinoidów o bardzo wysokich współczynnikach przenikania przez skórę
HK1137425A1 (en) Positively charged water-soluble prodrugs of aryl- and heteroarylpropionic acids with very fast skin penetration rate
HK1160725A1 (en) Carbonate prodrugs and methods of using the same
HK1147254A1 (en) 5-anilinoimidazopyridines and methods of use 5-
HK1137426A1 (en) Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate
EP2049482A4 (en) WATER-SOLUBLE PRODRUGS POSITIVE OF ARYL- AND HETEROARYLACETIC ACIDS WITH VERY FAST SKIN PENETRATION SPEED
EP2236150A4 (en) METHOD FOR INCREASING THE THERAPEUTIC EFFECTIVENESS OF CURCUMINOIDS AND THE LIKE
IL206125A0 (en) Azaindolizines and methods of use
HK1208184A1 (en) Positively charged water-soluble prodrugs of ketoprofen and related compounds with very fast skin penetration rate
HK1208214A1 (en) Positively charged water-soluble prodrugs of ketoprofen and related compounds with very fast skin penetration rate
HK1202115A1 (en) Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate
HK1200031A1 (en) Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate